Clinical Scientist Beth Hoskins specialises in molecular genetics at GOSH. She analyses DNA tests from patients with rare conditions to test for abnormalities. When not at GOSH, Beth volunteers for GoodGym, a community of runners from all over the UK who work out while helping others.
She has clocked up 1,600 kilometres jogging around her borough carrying out 500 'good deeds', including running every week to see an isolated 64-year-old called Paul.
A new artificially intelligent bodysuit to help understand how mobility is affected in boys with Duchenne will be trialled in a collaboration between researchers at Great Ormond Street Hospital (GOSH) and Imperial College London.
A daily tablet has been shown to reduce the debilitating symptoms experienced by children with Multiple Sclerosis (MS) and cut the chance of relapse by 82%. There are currently no treatments specifically approved for adolescents with MS and this is the first time that an MS drug has been trialled specifically in young people.